FUL vs OGN · P/E 21, $3.26B cap vs P/E 3.4, rev $6.40B
H B Fuller Company (FUL) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
H B Fuller Company (FUL) is a specialty chemicals company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
FUL does not have a complete income-statement cache yet.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
FUL currently screens at market cap $3.26B and trailing P/E 20.7. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the FUL and OGN stock pages for the full models.
Not investment advice.